Allogeneic HCT After Primary Induction Failure Beneficial in Leukemia
THURSDAY, Dec. 21, 2023 -- For patients with acute myeloid leukemia (AML), immediate allogeneic hematopoietic stem cell transplantation (HCT) after primary induction failure (PIF) offers long-term survival benefit, according to a study published...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Acute Leukemia | Acute Myeloid Leukemia | Leukemia | Pharmaceuticals | Stem Cell Therapy | Stem Cells | Study | Transplants